10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
65.05
+5.77 (9.73%)
At close: Nov 9, 2026, 4:00 PM EST
65.84
+0.79 (1.21%)
After-hours: Nov 9, 2026, 7:55 PM EST

10x Genomics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
618.58642.82610.79618.73516.41490.49
Revenue Growth
-3.62%5.24%-1.28%19.81%5.28%64.13%
Gross Profit
445.15444.38414.48409.31396.32416.4
Operating Income
-65.7-100.29-193.46-199.75-163.74-52.91
Net Income
-67.08-43.54-182.63-255.1-166-58.22
Earnings Per Share
-0.52-0.35-1.52-2.18-1.46-0.53
EPS Growth
------

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Single Cell Instruments
18.222.6735.2147.8758.5564.17
Spatial Instruments
23.0534.1157.575.6113.840.3
Single Cell Consumables
371.27363.21372.31420.32400.43390.88
Spatial Consumables
165.36143.98121.1259.2435.1627.86
Services
37.0132.7324.3215.78.437.28
License and Royalty
3.6946.140.32---
Revenue (Total)
618.58642.82610.79618.73516.41490.49

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
575.68523.41393.4388.7429.98587.45
Total Debt
75.7984.3682.6195.3795.1881.98
Net Cash (Debt)
499.89439.05310.79293.33334.81505.47
Net Cash Growth
26.52%41.27%5.95%-12.39%-33.76%-15.84%
Net Cash Per Share
3.883.522.582.502.944.58

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
99.7136.056.66-15.2-33.61-21.37
Capital Expenditures
-5.93-5.94-12.39-48.6-131.66-101.28
Free Cash Flow
93.77130.12-5.73-63.8-165.27-122.65
Free Cash Flow Growth
14.84%-----

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
71.96%69.13%67.86%66.15%76.75%84.89%
Operating Margin
-10.62%-15.60%-31.67%-32.28%-31.71%-10.79%
Pretax Margin
-10.53%-6.21%-29.09%-40.21%-31.36%-10.95%
Profit Margin
-10.84%-6.77%-29.90%-41.23%-32.15%-11.87%
FCF Margin
15.16%20.24%-0.94%-10.31%-32.00%-25.01%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
91.2515.86----
PS Ratio
13.833.212.8510.698.0833.92